Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Al Ghnam SA"'
Autor:
Farghaly MNMH; Dubai Medical College, Dubai, United Arab Emirates.; DHIC, Dubai, United Arab Emirates., Al Ghaithi ISM; Consultant, Pediatric Hematology/Oncology, Royal Hospital, Muskat, Oman., Mahamid WAR; Heart and Vascular Institute Cleveland Clinic, Abu Dhabi, United Arab Emirates., Adlan A; Bioethics Saudi National Institute of Health Research Forum, Riyadh, Saudi Arabia., AlGhamdi SM; Applied Clinical Research, King Fahad Medical City, Riyadh, Saudi Arabia., Al Shammari TM; College of Pharmacy, Riyadh Elm University, Riyadh, Saudi Arabia.; King Saud University, Riyadh, Saudi Arabia., Alqahtani NM; Evidence Based Medicine Committee, Riyadh, Saudi Arabia., Al Ghnam SA; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia., Ibrahim MSA; Insights Research Organization & Solutions (IROS), Abu Dhabi, United Arab Emirates., Al Mudaiheem H; Ministry of Health, Riyadh, Saudi Arabia., Chouikrat MZ; Sanofi, Dubai, United Arab Emirates., Aktham Y; Sanofi, Jeddah, Kingdom of Saudi Arabia., El Bagoury ME; Sanofi, Dubai, United Arab Emirates., Gowda AJ; Principal, Management Consulting, AMESA, IQVIA, Bangalore, India. ajayaramegowda@in.imshealth.com., Al Moaikel K; RWE Kingdom of Saudi Arabia, IQVIA, Riyadh, Saudi Arabia., Abdallah NSA; Director, Commercial Offerings, ME, IQVIA, Dubai, United Arab Emirates.
Publikováno v:
Drugs - real world outcomes [Drugs Real World Outcomes] 2023 Mar; Vol. 10 (1), pp. 1-9. Date of Electronic Publication: 2022 Nov 17.